Professor Kwang-Hyun Cho's research team has recently been highlighted for their work on developing an original technology ...

Five students from Ouachita Baptist University’s Patterson School of Natural Sciences have published research in the ...

A WOMAN has shared how she found a worryingly small early symptom of cancer on her husband’s toenail – which was dismissed by ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

“Broken skin barriers” are real. They’re the subject of great interest from " skinfluencers " on TikTok, but they’re also ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

Globally, liver cancer and head and neck cancers are more prevalent in Singapore and Asia. Read more at straitstimes.com.

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

New research from Emory University and international organizations could be a breakthrough in treating childhood brain cancer ...

Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.